GSA Capital Partners’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-55,527
| Closed | -$989K | – | 2021 |
|
|
2025
Q1 | $989K | Buy |
+55,527
| New | +$989K | 0.09% | 353 |
|
|
2023
Q2 | – | Sell |
-3,498
| Closed | -$210K | – | 1815 |
|
|
2023
Q1 | $210K | Buy |
+3,498
| New | +$210K | 0.02% | 1235 |
|
|
2022
Q3 | – | Sell |
-8,462
| Closed | -$588K | – | 1768 |
|
|
2022
Q2 | $588K | Buy |
+8,462
| New | +$588K | 0.09% | 395 |
|
|
2020
Q4 | – | Sell |
-2,181
| Closed | -$243K | – | 1485 |
|
|
2020
Q3 | $243K | Buy |
+2,181
| New | +$243K | 0.04% | 881 |
|
|
2020
Q1 | – | Sell |
-2,400
| Closed | -$202K | – | 1402 |
|
|
2019
Q4 | $202K | Sell |
2,400
-1,920
| -44% | -$162K | 0.02% | 1253 |
|
|
2019
Q3 | $323K | Sell |
4,320
-12,945
| -75% | -$968K | 0.04% | 831 |
|
|
2019
Q2 | $1.09M | Sell |
17,265
-4,871
| -22% | -$308K | 0.12% | 200 |
|
|
2019
Q1 | $1.07M | Buy |
22,136
+10,236
| +86% | +$493K | 0.11% | 268 |
|
|
2018
Q4 | $398K | Sell |
11,900
-17,300
| -59% | -$579K | 0.05% | 674 |
|
|
2018
Q3 | $1.53M | Sell |
29,200
-20,300
| -41% | -$1.06M | 0.08% | 399 |
|
|
2018
Q2 | $1.55M | Buy |
49,500
+29,100
| +143% | +$911K | 0.08% | 428 |
|
|
2018
Q1 | $445K | Sell |
20,400
-7,700
| -27% | -$168K | 0.02% | 1127 |
|
|
2017
Q4 | $568K | Buy |
28,100
+4,000
| +17% | +$80.9K | 0.03% | 880 |
|
|
2017
Q3 | $478K | Buy |
+24,100
| New | +$478K | 0.03% | 1000 |
|
|
2016
Q1 | – | Sell |
-14,300
| Closed | -$320K | – | 1846 |
|
|
2015
Q4 | $320K | Buy |
+14,300
| New | +$320K | 0.02% | 1428 |
|